ClinicalTrials.gg
Not yet recruitingNCT07417852Updated Aug 10, 2026

Effect of Cartoon Projection and Ball Squeezing on Pain During Venipuncture in Children

An interventional study of Cartoon Projection Distraction and ball squeezing distraction in Venipuncture Pain, sponsored by University of Baghdad. Not yet recruiting at 1 site in Iraq. Open to participants aged 2 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by University of Baghdad · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
2 Years to 12 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn which distraction method works better to reduce needle pain in children aged 4-12 years during blood draws.

The main questions it aims to answer are:

  • Does watching cartoon videos lower children's pain more than squeezing a stress ball?
  • Which method do parents prefer for their children?

    120 children will be randomly assigned to watch cartoons or squeeze a ball while nurses draw blood. Pain will be measured using a 0-10 pain scale right after the needle.

This study will help nurses choose the best way to make blood draws less painful for children.

Read the detailed description

This study compares two distraction methods (cartoon projection vs. ball squeezing) to reduce venipuncture pain in children aged 4-12 years.

120 children will be randomized 1:1 to receive either immersive cartoon videos or tactile stress ball distraction during routine blood draws at Karbala Pediatric Hospital.

Pain intensity (primary outcome) will be assessed using Visual Analogue Scale (VAS, 0-10; higher=worse) immediately post-procedure.

The study protocol received ethical approval from University of Baghdad College of Nursing (No. 77, Jan 29, 2026).

02

Conditions studied

  • Venipuncture Pain

Browse trials for

Keywords

  • Pediatric pain, venipuncture, distraction, cartoon projection , Ball squeezing
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 120 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

University of Baghdad is the lead sponsor of 170 studies on the registry; 69 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 4-12 years
  • Requiring venipuncture for routine blood testing
  • Able to watch cartoon video during procedure
  • Parental consent obtained

Exclusion criteria

Exclusion Criteria:

  • Developmental delay preventing cooperation
  • Severe anxiety disorder
  • Visual impairment
  • Non-English/Arabic speaking parents
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Cartoon Projection Arm

    Children receive immersive cartoon projection distraction during venipuncture

    Behavioral: Cartoon Projection Distraction · Behavioral: ball squeezing distraction

  • Experimental
    ball squeezing arm

    Children aged 4-12 years receive ball squeezing distraction during venipuncture

    Behavioral: ball squeezing distraction

Interventions

  • BehavioralCartoon Projection Distraction

    Immersive cartoon videos during venipuncture'

  • Behavioralball squeezing distraction

    Stress ball squeezing during venipuncture'

06

What researchers measure

Primary outcomes

  1. Analogue Scale (VAS) Pain Score (0-10; higher scores = worse pain)

    Child rates pain intensity (0-10 cm scale) immediately after needle insertion

    Time frame: 0-30 seconds post - venipuncture

Secondary outcomes

  1. Nurse-Observed Anxiety Level (1-5 scale; higher = worse)

    Child anxiety assessed by nurse observer rating (1-5 scale)

    Time frame: During venipuncture procedure

07

Study locations

1 site
  • Karbala Pediatric Teaching Hospital Al-Hussein Medical City Karbala, Iraq
    Karbala, Karbala Governorate 0694, Iraq
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 3 months is below that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2026
First posted
Feb 18, 2026
StartEst.
Sep 2026
Primary completionEst.
Dec 2026
CompletionEst.
Jan 2027
Last update
Aug 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07417852
Responsible party
Enas Ahmed Abdul Kareem (Principal Investigator, University of Baghdad) — Principal investigator
First posted
Feb 18, 2026
Start date
Sep 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
Aug 10, 2026

Study contacts

Enas Ahmed, PhD Student
Contact
ienas.ahmed1204a@conursing.uobaghdad.edu.iq
07806370150
Enas Ahmed, PhD Student
principal investigator · University of Baghdad College of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion